Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ribavirin
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05
- Strength
- 200 mg
- Dosage form
- Capsule
- Pack
- 10
- Registration no.
- 034073
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Novirin 200 mg capsule
Novirin 200 mg capsule contains Ribavirin 200 mg. It is registered with DRAP by Highnoon Laboratories Ltd (registration no. 034073). Its official price is PKR 466.61 for a pack of 10, about PKR 46.66 per capsule. This price has applied since 27 July 2026. Novirin is also available as 100 mg capsule, 400 mg capsule and 600 mg tablet. 17 other brands of Ribavirin 200 mg (capsule) are registered in Pakistan. Compare all brands and prices →
Other strengths of Novirin
Other brands of Ribavirin 200 mg
Official price over time
No change in the official DRAP price is recorded for this pack (10). Current price PKR 466.61, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Novirin 200 mg, 10: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/novirin-200-mg-034073-10-highnoon-laboratories-ltd/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 466.61 | 2026-07-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 034073Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
